Loading...

Home
ETF
TNGX

TNGX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

TNGX News

Tango Therapeutics CEO Barbara Weber Retires; Malte Peters Appointed as New CEO

Jan 08 2026Globenewswire

5 Biotech Stocks to Keep an Eye On for Possible Growth

Dec 17 2025NASDAQ.COM

Tango Therapeutics CEO to Present at 2026 J.P. Morgan Healthcare Conference

Dec 17 2025Globenewswire

Is Tango Therapeutics (TNGX) Overpriced Following a 200% Increase in the Past Year? An Updated Analysis of Its Valuation

Dec 14 2025Yahoo Finance

Oncolytics Biotech Secures FDA Approval for Phase 3 Immunotherapy Trial in Pancreatic Cancer

Dec 12 2025PRnewswire

Oncolytics Biotech Secures FDA Approval for Phase 3 Immunotherapy Trial in Pancreatic Cancer

Dec 12 2025Newsfilter

Tango Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 26 2025Globenewswire

Trump grants clemency to British billionaire Joe Lewis

Nov 13 2025Reuters

Tango Therapeutics (TNGX) Receives Upgrade to Buy: Reasons Explained

Oct 27 2025NASDAQ.COM

Guggenheim Upholds Buy Rating for Tango Therapeutics (TNGX)

Oct 25 2025NASDAQ.COM

Most Active Stocks in Pre-Market on October 23, 2025: BYND, VTYX, IONZ, TSLL, QBTS, RGTZ, IONQ, TNGX, NOK, QS, NIO, BBAI

Oct 23 2025NASDAQ.COM

Tango Therapeutics Secures $225 Million in Funding

Oct 23 2025Newsfilter

Tango Therapeutics Gains Ground with $225 Million Funding Round

Oct 23 2025SeekingAlpha

3 Highly Rated Stocks with a 'Perfect 10' Smart Score for Strong Buy Recommendations

Oct 13 2025TipRanks

IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates

Aug 01 2025NASDAQ.COM

Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines' Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Cancer

Jun 27 2025Newsfilter